Recurrent, localized urticaria and erythema multiforme: a review and management of cutaneous anthrax vaccine-related events.
The October 2001 domestic anthrax attacks affected 22 people, resulting in 5 fatalities. The added global terrorist threats have created an increasing need for homeland protection, as well as protection of our widely deployed forces battling terrorism. It is now relevant for physicians to be familiar with both clinical anthrax and adverse vaccine-related events associated with the resumption of the anthrax vaccine program. Dermatologists played a lead role in the initial response to the anthrax attack. We must be the lead providers most familiar with the cutaneous reactions that may be seen with the preventive vaccination. This article reviews the latest recommended evaluation and management of anthrax vaccine adverse events.
Gilson
Robert T
RT
Wright-Patterson Medical Center, Wright-Patterson Air Force Base, Ohio 45433, USA. robert.gilson@wpafb.af.mil
Schissel
Daniel J
DJ
D000328:Adult; D022122:Anthrax Vaccines / Q000009:adverse effects*; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008889:Military Personnel; D012008:Recurrence; D014581:Urticaria / Q000139:chemically induced* / Q000473:pathology* / Q000628:therapy
D022122:Anthrax Vaccines